Viewing Study NCT02880150


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2026-02-25 @ 8:17 PM
Study NCT ID: NCT02880150
Status: COMPLETED
Last Update Posted: 2016-08-26
First Post: 2013-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Physiological Characteristics of High Altitude Climbers
Sponsor: University Hospital, Grenoble
Organization:

Study Overview

Official Title: Physiological Characteristics of High Altitude Climbers
Status: COMPLETED
Status Verified Date: 2016-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ALTIPERF
Brief Summary: Climbing at high altitude and tolerating hypoxic environment require specific physiological adaptations. Large intersubjects differences exist regarding the ability to adapt to high altitude and hypoxia. The present study aims to characterise the physiological responses to hypoxia in a group of elite climbers by comparison to sea level athletes. We hypothesised that elite climbers would show better physiological responses to hypoxia and more preserved performances compared to sea level.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
ALTIPERF OTHER Grenoble University Hospital View